NIH-funded research R01 grant

Targeting cellular stress responses to improve liver health in obesity

Official title: Pharmacologic targeting of the UPR in obesity-linked liver dysfunction

Funded at Scripps Research Institute, the · NIH-11006357 · Data updated 2026-11-12

This study is looking at how a special process in our cells, called the unfolded protein response, might help improve liver problems caused by obesity and Type 2 diabetes, with the goal of finding new ways to treat these conditions for people who are struggling with them.

More Obesity research and trials

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionScripps Research Institute, the
NIH-funded
Lab location1 site (La Jolla, United States)
Project startJanuary 15, 2024
Project endNovember 30, 2027
Funding year2025
Award (this year)$689,587
NIH project number5R01DK137470-02
Project IDNIH-11006357 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are adults suffering from obesity-related liver conditions, such as nonalcoholic fatty liver disease (NAFLD) or nonalcoholic steatohepatitis (NASH).

Less likely to help

Patients who do not have obesity-related liver dysfunction or those with other unrelated health issues may not benefit from this research.

What this research studies

This research investigates how targeting the unfolded protein response (UPR) can help treat liver dysfunction associated with obesity and related conditions like Type 2 diabetes. The study focuses on understanding the signaling pathways activated by the UPR, particularly those involving the proteins IRE1, PERK, and ATF6, which play a role in cellular stress responses. By exploring how these pathways can be manipulated, the research aims to develop new therapeutic strategies to alleviate metabolic dysfunction in patients suffering from obesity-linked liver diseases.

Why it matters

Potential benefit: If successful, this research could lead to new treatments that improve liver health and metabolic function in individuals with obesity-related disorders.

How similar studies have gone: Previous research has shown promising results in targeting the UPR for metabolic disorders, indicating that this approach has potential for success.

Where this research is happening

  • Scripps Research Institute, the
    La Jolla, United States
    Active

Researchers

  • Principal investigator: Saez, Enrique — Scripps Research Institute, the
  • Study coordinator: Saez, Enrique

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.